These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 25735322)

  • 21. Hepatic cytochrome P450 2A6 and 2E1 status in peri-tumor tissues of patients with Opisthorchis viverrini-associated cholangiocarcinoma.
    Yongvanit P; Phanomsri E; Namwat N; Kampan J; Tassaneeyakul W; Loilome W; Puapairoj A; Khuntikeo N
    Parasitol Int; 2012 Mar; 61(1):162-6. PubMed ID: 21745589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infection with Opisthorchis felineus induces intraepithelial neoplasia of the biliary tract in a rodent model.
    Gouveia MJ; Pakharukova MY; Laha T; Sripa B; Maksimova GA; Rinaldi G; Brindley PJ; Mordvinov VA; Amaro T; Santos LL; Costa JMCD; Vale N
    Carcinogenesis; 2017 Sep; 38(9):929-937. PubMed ID: 28910999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors for cholangiocarcinoma in the lower part of Northeast Thailand: a hospital-based case-control study.
    Manwong M; Songserm N; Promthet S; Matsuo K
    Asian Pac J Cancer Prev; 2013; 14(10):5953-6. PubMed ID: 24289607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opisthorchis viverrini-antigen induces expression of MARCKS during inflammation-associated cholangiocarcinogenesis.
    Techasen A; Loilome W; Namwat N; Duenngai K; Cha'on U; Thanan R; Sithithaworn P; Miwa M; Yongvanit P
    Parasitol Int; 2012 Mar; 61(1):140-4. PubMed ID: 21763456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Annexin A1: A new immunohistological marker of cholangiocarcinoma.
    Hongsrichan N; Rucksaken R; Chamgramol Y; Pinlaor P; Techasen A; Yongvanit P; Khuntikeo N; Pairojkul C; Pinlaor S
    World J Gastroenterol; 2013 Apr; 19(16):2456-65. PubMed ID: 23674846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Control of Opisthorchis viverrini infection for cholangiocarcinoma prevention].
    Buisson Y
    Bull Soc Pathol Exot; 2017 Feb; 110(1):61-67. PubMed ID: 28105582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic Biomarkers and the Wnt/β-Catenin Pathway in Opisthorchis viverrini-associated Cholangiocarcinoma: A Scoping Review on Therapeutic Opportunities.
    Kafle A; Suttiprapa S; Muhammad M; Tenorio JCB; Mahato RK; Sahimin N; Loong SK
    PLoS Negl Trop Dis; 2024 Sep; 18(9):e0012477. PubMed ID: 39236081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A combination of liver fluke infection and traditional northeastern Thai foods associated with cholangiocarcinoma development.
    Sriraj P; Boonmars T; Aukkanimart R; Songsri J; Sripan P; Ratanasuwan P; Boonjaraspinyo S; Wongchalee N; Laummaunwai P
    Parasitol Res; 2016 Oct; 115(10):3843-52. PubMed ID: 27271702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PRKAR1A overexpression is associated with increased ECPKA autoantibody in liver fluke-associated cholangiocarcinoma: application for assessment of the risk group.
    Loilome W; Yooyuen S; Namwat N; Sithithaworn P; Puapairoj A; Kano J; Noguchi M; Miwa M; Yongvanit P
    Tumour Biol; 2012 Dec; 33(6):2289-98. PubMed ID: 22922884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary microRNA-192 and microRNA-21 as potential indicators for liver fluke-associated cholangiocarcinoma risk group.
    Silakit R; Loilome W; Yongvanit P; Thongchot S; Sithithaworn P; Boonmars T; Koonmee S; Titapun A; Khuntikeo N; Chamadol N; Techasen A; Namwat N
    Parasitol Int; 2017 Aug; 66(4):479-485. PubMed ID: 26456596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histological confirmation of periductal fibrosis from ultrasound diagnosis in cholangiocarcinoma patients.
    Chamadol N; Pairojkul C; Khuntikeo N; Laopaiboon V; Loilome W; Sithithaworn P; Yongvanit P
    J Hepatobiliary Pancreat Sci; 2014 May; 21(5):316-22. PubMed ID: 24420706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ultrasonography as a tool for monitoring the development and progression of cholangiocarcinoma in Opisthorchis viverrini/ dimethylnitrosamine-induced hamsters.
    Plengsuriyakarn T; Eursitthichai V; Labbunruang N; Na-Bangchang K; Tesana S; Aumarm W; Pongpradit A; Viyanant V
    Asian Pac J Cancer Prev; 2012; 13(1):87-90. PubMed ID: 22502719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increase of exostosin 1 in plasma as a potential biomarker for opisthorchiasis-associated cholangiocarcinoma.
    Khoontawad J; Hongsrichan N; Chamgramol Y; Pinlaor P; Wongkham C; Yongvanit P; Pairojkul C; Khuntikeo N; Roytrakul S; Boonmars T; Pinlaor S
    Tumour Biol; 2014 Feb; 35(2):1029-39. PubMed ID: 24018821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subtle to severe hepatobiliary morbidity in Opisthorchis viverrini endemic settings in southern Laos.
    Ayé Soukhathammavong P; Rajpho V; Phongluxa K; Vonghachack Y; Hattendorf J; Hongvanthong B; Rasaphon O; Sripa B; Akkhavong K; Hatz C; Odermatt P
    Acta Trop; 2015 Jan; 141(Pt B):303-9. PubMed ID: 25275346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of c-Ski oncoprotein in carcinogenesis of cholangiocacinoma induced by Opisthorchis viverrini and N-nitrosodimethylamine.
    Boonmars T; Wu Z; Boonjaruspinyo S; Puapairoj A; Kaewsamut B; Nagano I; Pinlaor S; Yongvanit P; Wonkchalee O; Juasook A; Sudsarn P; Srisawangwong T
    Pathol Oncol Res; 2011 Jun; 17(2):219-27. PubMed ID: 20853076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered gene expression in Opisthorchis viverrini-associated cholangiocarcinoma in hamster model.
    Loilome W; Yongvanit P; Wongkham C; Tepsiri N; Sripa B; Sithithaworn P; Hanai S; Miwa M
    Mol Carcinog; 2006 May; 45(5):279-87. PubMed ID: 16550611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors for Opisthorchis viverrini Infection in Nong Khai Province, Thailand.
    Chudthaisong N; Promthet S; Bradshaw P
    Asian Pac J Cancer Prev; 2015; 16(11):4593-6. PubMed ID: 26107209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutations of KRAS and TP53 in a minor proportion of Opisthorchis viverrini-associated cholangiocarcinomas in a hamster model.
    Tangkawattana S; Kaewkes S; Pairojkul C; Tangkawattana P; Sripa B
    Asian Pac J Cancer Prev; 2008; 9(1):101-6. PubMed ID: 18439086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Milk fat globule epidermal growth factor 8 serves a novel biomarker of opisthorchiasis-associated cholangiocarcinoma.
    Wu Z; Boonmars T; Nagano I; Loilome W; Yongvanit P; Khuntikeo N; Nielsen PS; Paorojkul C; Takahashi Y; Maekawa Y
    Tumour Biol; 2014 Mar; 35(3):1985-95. PubMed ID: 24122204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival of Patients with Cholangiocarcinoma Receiving Surgical Treatment in an O. viverrini Endemic Area in Thailand: A Retrospective Cohort Study.
    Chansitthichok S; Chamnan P; Sarkhampee P; Lertsawatvicha N; Voravisutthikul P; Wattanarath P
    Asian Pac J Cancer Prev; 2020 Apr; 21(4):903-909. PubMed ID: 32334449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.